Contact this trialFirst, we need to learn more about you.
Anticoagulant
Apixaban for Blood Clot and Low Platelet Count
Recruiting1 awardPhase < 1
Boston, Massachusetts
This trial aims to test a new dosage of Apixaban for treating cancer patients with blood clots and low platelet counts. Researchers want to see if this treatment is safe and if it reduces bleeding
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service